F2g Limited

F2g Limited is a biotechnology company based in Manchester, UK, specializing in the development of innovative antifungal therapies. The organization focuses on addressing the growing challenge of fungal infections, particularly in immunocompromised patients. F2g's research emphasizes the discovery and advancement of novel compounds that target resistant fungal strains, aiming to improve patient outcomes and expand treatment options in the field of infectious diseases. Their commitment to scientific excellence positions them as a key player in the biopharmaceutical landscape.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

11 Patents

#26 in Manchester

#1,600 in United Kingdom

#51,801 in the World

Manchester, United Kingdom

F2g Limited

Forward Citations = 21

24 inventors:

Derek Law (7 out of 7 patents)

Graham Edward Morris Sibley (7 out of 9 patents)

Jason David Oliver (7 out of 7 patents)

4. Michael Birch (6 out of 6 patents)

5. Gareth Morse Davies (3 out of 23 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: F2g Limited. Retrieved from https://idiyas.com/company/f2g

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

7 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]